H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis
Clinical trial NCT05872841 · UNKNOWN
Trial details
- NCT number
- NCT05872841
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.